L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
ATC class of level 4 – chemical subgroup
This page lists the patient medication information or the product monograph for 3 drugs in this drug class and its subclasses.
- 3 prescription (Rx)
Place in the ATC system
- L Antineoplastic and immunomodulating agents 1,069 drugs
- L01 Antineoplastic agents 616 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
-
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01EK01 Axitinib 2 drugs
- L01EK04 Fruquintinib 1 drug
-
L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 3 drugs
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 118 drugs
- L01 Antineoplastic agents 616 drugs
Active ingredients of the class
- Axitinib 2 drugs
- Fruquintinib 1 drug
Drugs in the class and its subclasses
| Drug | Rx or OTC |
|---|---|
| Fruzaqla (L01EK04 Fruquintinib) | prescription (Rx) |
| Inlyta (Pfizer Canada, 1 mg, 5 mg) (L01EK01 Axitinib) | prescription (Rx) |
| Inlyta (Pfizer Canada, 3 mg, 7 mg) PM (L01EK01 Axitinib) | prescription (Rx) |
Other classes of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 30 drugs
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 16 drugs
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 3 drugs
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 4 drugs
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 5 drugs
- L01EF Cyclin-dependent kinase (CDK) inhibitors 7 drugs
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 1 drug
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 5 drugs
- L01EJ Janus-associated kinase (JAK) inhibitors 3 drugs
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 4 drugs
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 3 drugs
- L01EX Other protein kinase inhibitors 30 drugs
Other names of the drug class
- English (United Kingdom): L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors
- German: L01EK Vaskulärer endothelialer Wachstumsfaktor-Rezeptor (VEGFR)-Tyrosinkinase-Inhibitoren
- German (Austria): L01EK Vaskulärer endothelialer Wachstumsfaktor-Rezeptor (VEGFR)-Tyrosinkinase-Inhibitoren
- Italian: L01EK Inib. Tirosina chinasi recet. Fattore crescita END. VASC ( VEGFR)
- Turkish: L01EK Vasküler endotelyal büyüme faktörü reseptörü (VEGFR) tirozin kinaz inhibitörleri
- German (Switzerland): L01EK Vaskulärer endothelialer Wachstumsfaktor-Rezeptor (VEGFR)-Tyrosinkinase-Inhibitoren
- Italian (Switzerland): L01EK Inib. Tirosina chinasi recet. Fattore crescita END. VASC ( VEGFR)
- Dutch: L01EK Vasculaire endotheliale groeifactorreceptor(VEGFR)-tyrosinekinaseremmers
Sources
- Patient medication information and product monographs: Health Canada, Drug Product Database
- Active ingredients, ATC codes and Rx or OTC status: Health Canada, Drug Product Database
- World Health Organization (WHO): ATC/DDD system, class L01EK
Ask your doctor or pharmacist for advice.